Dr. Reddy's new generic is now available in the US

Dr. Reddy's Laboratories announces the launch of Aripiprazole tablets, USP tablets in the U.S. Market


Dr. Reddy's Laboratories announced that it has launched Aripiprazole tablets, USP, in 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, a therapeutic equivalent generic version of Abilify (aripiprazole) tablets in the United States market approved by the U.S. Food & Drug Administration (USFDA).

The Abilify brand and generic tablets had U.S. sales of approximately $3.1 billion MAT for the most recent twelve months ending in August 2016 according to IMS Health.

Dr.Reddy's Aripiprazole tablets 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg are available in bottle count sizes of 30.

Abilify is a registered trademark of Otsuka Pharmaceutical Company.


Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

National Health Policy

Is National Health Policy 2017 helpful for patients?

Send this article by email